Loading...
Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies
BACKGROUND: Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We examined the effect of tofacitinib induction treatment on Inflammatory Bowel Disease Questionnaire (IBDQ) items in adults with moderate to severe UC. METHODS: Data were pooled f...
Na minha lista:
| Udgivet i: | Inflamm Bowel Dis |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8205629/ https://ncbi.nlm.nih.gov/pubmed/32794567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izaa193 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|